Antidepressant Efficacy of Psychotherapy and Citalopram in Patients With Breast Cancer and Major Depression

  • STATUS
    Recruiting
  • End date
    Sep 6, 2023
  • participants needed
    40
  • sponsor
    Hospital Universitari de Bellvitge
Updated on 6 October 2021
mammogram

Summary

To provide evidence on the antidepressant efficacy of two therapeutic treatments: pharmacological treatment (citalopram) and psychotherapy treatment, in women diagnosed with breast cancer and major depression.

Details
Condition Breast Cancer, Major Depressive Episode, Breast Cancer Diagnosis, breast carcinoma, cancer, breast, major depressive disorder, single episode
Treatment citalopram, Psychotherapy
Clinical Study IdentifierNCT05063604
SponsorHospital Universitari de Bellvitge
Last Modified on6 October 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Female patients first time diagnosed with breast cancer (stage I, II, III, or IV) between ages 18 and 75 (both inclusive)
Patients with a "moderate-severe" level of emotional distress who meet the diagnostic criteria for major depression for at least two weeks or adjustment disorder with depressive mood for at least two months, according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria (DSM-V), during the twelve months following the diagnose of breast cancer
Informed Consent Form Signature

Exclusion Criteria

Women who are pregnant or breastfeeding
Suicide risk
Metastatic brain disease
Personal History of oncological disease
Personal History of serious somatic disease (cardiac, hepatic, respiratory, endocrinological, neurological and haematological)
Personal History of organic brain disorder, substance abuse/dependence
Personal History of psychotic disorder, bipolar disorder and/or mental retardation
Contraindications of citalopram treatment
Taking antidepressants after the breast cancer diagnosis
Psychotherapy treatment after breast cancer diagnosis
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note